FDA Has Granted Innocan Pharma a Meeting Date for LPT-CBD for Chronic Pain
/PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), is pleased to announce significant advancements...
Stay updated with breaking news from Ahuva Cern. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), is pleased to announce significant advancements...
The regulatory approval process with the U.S. Food and Drug Administration has commenced for Innocan's LPT-CBD release technology, marking a key step in the advancement of non-opioid pain management HERZLIYA
A Case Report Published in Frontiers in Veterinary Science Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - April 29, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the
INNOCAN PHARMA CORPORATION Management's Discussion and Analysis For the year ended December 31, 2021 1. MANAGEMENT'S DISCUSSION AND... | April 24, 2022
Anzeige / WerbungSatte 48 Millionen Aktien, ein Plus von rund 18 Mio. Aktien seit dem IPO, nennt eine der bekanntesten Selfmade-Milliardärinnen der Welt über eine der von ihr kontrollierten Beteiligungsfirmen